TrialYonsei medical journal2007

A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.

Sung Joon Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.